PharmaCompass

Cambridge Biomedical Inc
Inhibition of Btk with CC-292
Full Screen View

Cambridge Biomedical Inc

About, Contact Details

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

Corporate Presentation, Validating Multiple Matrices to Expedite Development, Representative Instrument Capabilities, Luminex Technology, Luminex Assay Validation , Lab Developed Tests and the FDA, Inhibition of Btk with CC-292, HPLC For Clinical Applications, Flow cytometry, EnPlex- A high-throughput method of Enzyme Activity, Development & Validation of Luminex Based Cytokine Assays, Development of Novel FACS & IP/Western-Blot Assays, Collaborative Assay Development and Design , Challenges of Multiplex Assay Validation, Assay Development and Validation, Art of Auditing Bioanalytical Laboratories, Application of Immunological Methods

VIDEO(s)

VIDEO, CBI Video Services, Collaborative Assay Development, Flow Cytometry at Cambridge Biomedical, High Throughput Multiplexed Assay , Lab Developed Tests and the FDA, Luminex Assay Validation, MassBio CRO/CMO Symposium, MSD versus ELISA technology , Our Location, PCR at Cambridge Biomedical